Huang Haohao, Jin Weidong, Sun Huiling, Diao Bo, Wang Ping, Jia Jiankun, Ma Dandan, Zhang Yi
Department of Neurosurgery, General Hospital of Central Theater Command of PLA, Wuhan 430071, Hubei, China; General Hospital Of Central Theater Command and Hubei Key Laboratory of Central Nervous System Tumor and Intervention, Wuhan, Hubei 430070, China; Wuhan University of Science and Technology, Wuhan, Hubei, China.
Department of General Surgery, General Hospital of Central Theater Command of PLA, Wuhan 430071, Hubei, China.
J Nutr Health Aging. 2025 Aug;29(8):100606. doi: 10.1016/j.jnha.2025.100606. Epub 2025 Jun 18.
This study investigated the impact of clinical frailty on short-term outcomes of simultaneous colorectal cancer (CRC) and colorectal cancer liver metastasis (CRLM) resections.
Data of older patients ≥ 60 years old undergoing simultaneous CRC/CRLM resections between 2005 and 2018 were identified in the United States (US) Nationwide Inpatient Sample (NIS) database.
Frailty was determined using the Hospital Frailty Risk Score (HFRS) according to the International Classification of Diseases Ninth and Tenth (ICD-9 and ICD-10) codes. Study outcomes included mortality, prolonged hospital stay (LOS), non-routine discharge, and complications.
Data of 4514 patients were analyzed. Frailty was significantly associated with increased risks of in-hospital mortality (adjusted odds ratio [aOR] = 3.65, 95% confidence interval [CI]: 2.52, 5.28), non-routine discharge (aOR = 2.44, 95% CI: 2.08, 2.87), prolonged LOS (aOR = 3.07, 95% CI: 2.60, 3.61), overall complications (aOR = 3.47, 95% CI: 3.03, 3.97), sepsis (aOR = 13.73, 95% CI: 9.76, 19.31), respiratory failure (aOR = 4.99, 95% CI: 3.80, 6.57), acute kidney injury (AKI) (aOR = 6.42, 95% CI: 4.83, 8.52), and acute liver failure (aOR = 2.10, 95% CI: 1.38, 3.21), as well as 32.69 thousand USD higher total hospital costs (95% CI: 28.41, 36.97) than no frailty. Incorporating frailty with traditional demographic and clinical risk factors improved in-hospital mortality prediction (area under ROC curve [AUC]: 0.765 to 0.799).
In older patients aged ≥ 60 years undergoing simultaneous CRC and CRLM resection, HFRS-defined frailty is a significant predictor of adverse in-hospital outcomes. The addition of HFRS-defined frailty to demographic and clinical variables in predictive models improved the AUC for mortality prediction. Incorporating frailty assessment into the preoperative risk stratification and decision-making process for these patients may support surgeons in delivering more personalized and effective care.
本研究调查了临床衰弱对同时性结直肠癌(CRC)和结直肠癌肝转移(CRLM)切除术短期预后的影响。
在美国国家住院患者样本(NIS)数据库中确定了2005年至2018年间接受同时性CRC/CRLM切除术的60岁及以上老年患者的数据。
根据国际疾病分类第九版和第十版(ICD-9和ICD-10)编码,使用医院衰弱风险评分(HFRS)确定衰弱情况。研究结局包括死亡率、住院时间延长(LOS)、非常规出院和并发症。
分析了4514例患者的数据。衰弱与住院死亡率增加(调整优势比[aOR]=3.65,95%置信区间[CI]:2.52,5.28)、非常规出院(aOR=2.44,95%CI:2.08,2.87)、住院时间延长(aOR=3.07,95%CI:2.60,3.61)、总体并发症(aOR=3.47,95%CI:3.03,3.97)、脓毒症(aOR=13.73,95%CI:9.76,19.31)、呼吸衰竭(aOR=4.99,95%CI:3.80,6.57)、急性肾损伤(AKI)(aOR=6.42,95%CI:4.83,8.52)和急性肝衰竭(aOR=2.10,95%CI:1.38,3.21)显著相关,且总住院费用比非衰弱患者高32690美元(95%CI:28410,36970)。将衰弱与传统人口统计学和临床风险因素相结合可改善住院死亡率预测(ROC曲线下面积[AUC]:从0.765至0.799)。
在接受同时性CRC和CRLM切除术的60岁及以上老年患者中,HFRS定义的衰弱是住院不良结局的重要预测因素。在预测模型中,将HFRS定义的衰弱添加到人口统计学和临床变量中可提高死亡率预测的AUC。将衰弱评估纳入这些患者的术前风险分层和决策过程可能有助于外科医生提供更个性化和有效的护理。